TG Therapeutics Statistics
NASDAQ: TGTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
53.34+0.39 (+0.74%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
TG Therapeutics by the numbers
TG Therapeutics has a market capitalization of $8.17 billion based on 153.08M shares outstanding. Its trailing P/E ratio is 19.4, and its forward P/E is 19.7. The stock trades 0.4% below its 50-day average and 28.1% above its 200-day average.
Average daily trading volume is 2.01M shares, or about $107.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TGTX valuation vs. peer median
| Metric | TGTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.17B | $7.98B | +2% |
| Avg. volume | 2.01M | 1.55M | +30% |
Peer median across 8 companies: ARWR, CYTK, SYRE, PRAX, AXSM, IONS, PTGX, AMRX.
Valuation
- Market cap
- $8.17B
- P/E (TTM)
- 19.40
- Forward P/E
- 19.70
- Price / sales (latest FY)
- 13.25
- EPS (TTM)
- $2.75
- Shares outstanding
- 153.08M
Price and trading
- Previous close
- 52.95
- Open
- 53.34
- Day range
- 52.12 – 53.90
- 52-week range
- 26.76 – 59.30
- 52-week change
- +49.20%
- Beta
- —
- Volume
- 1.74M
- Average volume
- 2.01M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 8.17B
- Pe
- 19.40
- Forward Pe
- 19.70
- Eps
- 2.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 59.30
- Week52 Low
- 26.76
- Avg Volume
- 2.01M
- Shares Outstanding
- 153.08M
- Ma50
- 53.56
- Ma200
- 41.65
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -10.05%
- Pct From52w Low
- 99.33%